QSI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Quantum-Si Inc (QSI) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with significant revenue and net income declines. Analyst sentiment is neutral to negative, with a reduced price target and a 'Hold' rating. Technical indicators suggest the stock is overbought, and there are no strong positive catalysts or trading signals to support a buy decision.
The MACD histogram is positive and expanding, indicating bullish momentum. However, the RSI is at 84.711, signaling the stock is overbought. Moving averages are converging, and the stock is trading near its resistance level (R1: 1.018). This suggests limited upside potential in the short term.
Quantum-Si will present at the AACR annual meeting, showcasing its single-molecule protein sequencing technology, which could generate interest in its innovative applications.
The company's Q4 2025 financial performance was poor, with significant declines in revenue (-62.16% YoY), net income (-46.83% YoY), and EPS (-65.22% YoY). Gross margin also dropped significantly to 27.05%. Analyst sentiment is neutral to negative, with a reduced price target and a 'Hold' rating. Additionally, the stock is overbought, limiting its short-term upside potential.
In Q4 2025, Quantum-Si reported a revenue drop of -62.16% YoY to $451,000, a net income decline of -46.83% YoY to -$17.61 million, and an EPS drop of -65.22% YoY to -$0.08. Gross margin fell to 27.05%, down -47.14% YoY. These metrics indicate significant financial struggles.
Canaccord analyst Kyle Mikson lowered the price target from $1.50 to $1 and maintained a 'Hold' rating, citing poor Q4 2025 results and framing 2026 as a 'transition year' due to the focus on launching the Proteus platform.
